Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Development of a nationwide genomic screening network for lung cancer with rare driver oncogenes and investigation of the mechanism of drug resistance

Date

08 Oct 2016

Session

Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Presenters

Shingo Matsumoto

Authors

S. Matsumoto

Author affiliations

  • Department Of Thoracic Oncology, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP
More

Resources

Resources from the same session

Treatment decisions at ALK TKI resistance

Presenter: Maurice Perol

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

Introduction

Presenter: Yuichiro Ohe

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

Conclusions and clinical perspectives

Presenter: Solange Peters

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings